IMTX

Conviction 40HealthcareScan · Thu, Jun 25, 2026

IMTX$9.54-4.84%

ResistanceSupportVol 14

Vol MA14 439.11K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Immatics N.V.Biotechnologywww.immatics.com ↗

Price9.54

Change-4.84%

Gap+0.80%

Rel volume0.81×

Avg volume524.17K

Avg $ vol5.2M

SMA 209.85

SMA 5010.64

SMA 2009.88

Price vs 50-10.37%

Price vs 200-3.52%

MA stackmixed

50/200 cross—

Supertrenddown · 10.71

RSI (14)43

MACD hist0.06

MACD crossbull · 3d

Stoch %K / %D52 / 61

ADX (14)19

+DI / −DI19 / 25

RSI divergence—

MACD divergence—

ATR %+5.69%

ADR %5.44%

52w high11.87

52w low5.09

From 52w high-19.67%

Above 52w low+87.33%

New 52w highNo

SqueezeOff

Bollinger width30.02%

%B0.39

Donchian pos25.76%

Donchian high11.77

Donchian low8.76

AVWAP (52w high)10.25

vs AVWAP high-6.96%

AVWAP (52w low)9.52

vs AVWAP low+0.12%

OBV trendDown

Chaikin MF (20)-0.22

Today vs 20d0.81×

Avg vol (14d)439.11K

Avg vol (20d)524.17K

Avg $ vol (20d)5.2M

Market cap1.28B

RS 3m (vs SPY)-3.34%

RS 6m (vs SPY)-10.17%

RS line new highNo

Trend template5/8

Technical rank24.4

1 week+0.16%

1 month-14.79%

3 months-2.10%

6 months-7.87%

1 year+75.28%

YTD-8.76%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target19.64

Target upside105.98%

Analyst ratingBuy

Institutional80.68%

Ent. value1.28B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out134.1M

Employees407

ListedThu, Jul 2, 2020

Free float91.58M

Float %75.3%

Short interest4.8M

Days to cover9.5d

Short volume27.9%

Squeeze score35 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.50 vs −$0.42

Last surprise-19.1% miss

Setup gradeD

Conviction40 / 100

Pattern quality—

Tech rank24.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.90

Support8.88

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in IMTX

All disclosures →

No recent disclosed trades by Congress in IMTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMTX · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Hothum Mathias Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
ATIEH MICHAEL G Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
Carter Paul Rutherford Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
Chambre Peter Alan Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
Forster Eliot Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
Mason Heather L Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
REICIN ALISE Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
Stone Adam Leo Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18
PERCEPTIVE ADVISORS LLC Director · Stock Option (Right to Buy) · 2026-06-16	Grant	48K	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in IMTX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.